Short-term glutamine supplementation decreases lung inflammation and the receptor for advanced glycation end-products expression in direct acute lung injury in mice

BMC Pulmonary Medicine

Hui-Ling Huang²  Wei-Chih Lai²  He-Jia Pan²  Chi-Chung Chen¹  Huey-Mei Shaw²  Yin-Ching Chuang¹ 

[1] Department of Medicine, Medical Research, Chi Mei Medical Center, Tainan, Taiwan;Department of Health and Nutrition, Chia-Nan University of Pharmacy and Science, Tainan, Taiwan

关键词: Inflammation;    Receptor for advanced glycation end-products (RAGE);    Acute lung injury (ALI);    Glutamine (GLN);   

Others  :  862698
DOI  :  10.1186/1471-2466-14-115

 received in 2013-03-21, accepted in 2014-07-10,  发布年份 2014

【 摘 要 】

Background

Glutamine (GLN) has been reported to improve clinical and experimental sepsis outcomes. However, the mechanisms underlying the actions of GLN remain unclear, and may depend upon the route of GLN administration and the model of acute lung injury (ALI) used. The aim of this study was to investigate whether short-term GLN supplementation had an ameliorative effect on the inflammation induced by direct acid and lipopolysaccharide (LPS) challenge in mice.

Methods

Female BALB/c mice were divided into two groups, a control group and a GLN group (4.17% GLN supplementation). After a 10-day feeding period, ALI was induced by intratracheal administration of hydrochloric acid (pH 1.0; 2 mL/kg of body weight [BW]) and LPS (5 mg/kg BW). Mice were sacrificed 3 h after ALI challenge. In this early phase of ALI, serum, lungs, and bronchoalveolar lavage fluid (BALF) from the mice were collected for further analysis.

Results

The results of this study showed that ALI-challenged mice had a significant increase in myeloperoxidase activity and expression of interleukin (IL)-1β, IL-6, and tumor necrosis factor-α in the lung compared with unchallenged mice. Compared with the control group, GLN pretreatment in ALI-challenged mice reduced the levels of receptor for advanced glycation end-products (RAGE) and IL-1β production in BALF, with a corresponding decrease in their mRNA expression. The GLN group also had markedly lower in mRNA expression of cyclooxygenase-2 and NADPH oxidase-1.

Conclusions

These results suggest that the benefit of dietary GLN may be partly contributed to an inhibitory effect on RAGE expression and pro-inflammatory cytokines production at an early stage in direct acid and LPS-induced ALI in mice.

【 授权许可】

   
2014 Chuang et al.; licensee BioMed Central Ltd.

【 图 表 】

【 参考文献 】

• [1]Raghavendran K, Nemzek J, Napolitano LM, Knight PR: Aspiration-induced lung injury. Crit Care Med 2011, 39:818-826.
• [2]Matthay MA, Zemans RL: The acute respiratory distress syndrome: pathogenesis and treatment. Annu Rev Pathol 2011, 6:147-163.
• [3]Chabot F, Mitchell JA, Gutteridge JM, Evans TW: Reactive oxygen species in acute lung injury. Eur Respir J 1998, 11:745-757.
• [4]Puneet P, Moochhala S, Bhatia M: Chemokines in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 2005, 288:L3-L15.
• [5]Guo WA, Knight PR, Raghavendran K: The receptor for advanced glycation end products and acute lung injury/acute respiratory distress syndrome. Intensive Care Med 2012, 38:1588-1598.
• [6]Su X, Looney MR, Gupta N, Matthay MA: Receptor for advanced glycation end-products (RAGE) is an indicator of direct lung injury in models of experimental lung injury. Am J Physiol Lung Cell Mol Physiol 2009, 297:L1-L5.
• [7]Zhang H, Tasaka S, Shiraishi Y, Fukunaga K, Yamada W, Seki H, Ogawa Y, Miyamoto K, Nakano Y, Hasegawa N, Miyasho T, Maruyama I, Ishizaka A: Role of soluble receptor for advanced glycation end products on endotoxin-induced lung injury. Am J Respir Crit Care Med 2008, 178:356-362.
• [8]Uchida T, Shirasawa M, Ware LB, Kojima K, Hata Y, Makita K, Mednick G, Matthay ZA, Matthay MA: Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am J Respir Crit Care Med 2006, 173:1008-1015.
• [9]Huttunen HJ, Fages C, Rauvala H: Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol Chem 1999, 274:19919-19924.
• [10]Jian MY, Koizumi T, Kubo K: Effects of nitric oxide synthase inhibitor on acid aspiration-induced lung injury in rats. Pulm Pharmacol Ther 2005, 18:33-39.
• [11]Lima Trajano ET, Sternberg C, Caetano M, Santos Silva MA, Porto LC, Santos JC, Ribeiro ML, Magalhães CB, Zin WA, Benjamim CF, Valença SS: Endotoxin-induced acute lung injury is dependent upon oxidative response. Inhal Toxicol 2011, 23:918-926.
• [12]Weitzel LR, Wischmeyer PE: Glutamine in critical illness: the time has come, the time is now. Crit Care Clin 2010, 26:515-525. ix-x
• [13]Wischmeyer PE: Glutamine in acute lung injury: the experimental model matters. Am J Physiol Lung Cell Mol Physiol 2009, 296:L286-L287.
• [14]Hu YM, Pai MH, Yeh CL, Hou YC, Yeh SL: Glutamine administration ameliorates sepsis-induced kidney injury by downregulating the high-mobility group box protein-1-mediated pathway in mice. Am J Physiol Renal Physiol 2012, 302:F150-F158.
• [15]Kwon WY, Suh GJ, Kim KS, Jo YH, Lee JH, Kim K, Jung SK: Glutamine attenuates acute lung injury by inhibition of high mobility group box protein-1 expression during sepsis. Brit J Nutr 2010, 103:890-898.
• [16]Reeves PG, Nielsen FH, Fahey GC Jr: AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993, 123:1939-1951.
• [17]Lai YN, Yeh SL, Lin MT, Shang HF, Yeh CL, Chen WJ: Glutamine supplementation enhances mucosal immunity in rats with gut-derived sepsis. Nutrition 2004, 20:286-291.
• [18]Yeh SL, Lai YN, Shang HF, Lin MT, Chen WJ: Effects of glutamine supplementation on innate immune response in rats with gut-derived sepsis. Br J Nutr 2004, 91:423-429.
• [19]Chiang SR, Chuang YC, Tang HJ, Chen CC, Chen CH, Lee NY, Chou CH, Ko WC: Intratracheal colistin sulfate for BALB/c mice with early pneumonia caused by carbapenem-resistant Acinetobacter baumannii. Crit Care Med 2009, 37:2590-2595.
• [20]Akcan A, Muhtaroglu S, Akgun H, Akyildiz H, Kucuk C, Sozuer E, Yurci A, Yilmaz N: Ameliorative effects of bombesin and neurotensin on trinitrobenzene sulphonic acid-induced colitis, oxidative damage and apoptosis in rats. World J Gastroenterol 2008, 14:1222-1230.
• [21]Osburn WO, Karim B, Dolan PM, Liu G, Yamamoto M, Huso DL, Kensler TW: Increased colonic inflammatory injury and formation of aberrant crypt foci in Nrf2-deficient mice upon dextran sulfate treatment. Int J Cancer 2007, 121:1883-1891.
• [22]Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193:265-275.
• [23]Huang CJ, Shaw HM: Tissue vitamin E status is compromised by dietary protein insufficiency in young growing rats. J Nutr 1994, 124:571-579.
• [24]Shaw HM, Zhang LY, Huang HL: The effects of sucrose water and food restriction on antioxidative status in rats. Chia Nan Ann Bull 2009, 35:172-180.
• [25]Singleton KD, Wischmeyer PE: Glutamine attenuates inflammation and NF-kappaB activation via Cullin-1 deneddylation. Biochem Biophys Res Commun 2008, 373:445-449.
• [26]Zhou GJ, Zhang H, Zhi SD, Jiang GP, Wang J, Zhang M, Gan JX, Xu SW, Jiang GY: Protective effect of raloxifene on lipopolysaccharide and acid- induced acute lung injury in rats. Acta Pharmacol Sin 2007, 28:1585-1590.
• [27]Abraham E, Arcaroli J, Carmody A, Wang H, Tracey KJ: HMG-1 as a mediator of acute lung inflammation. J Immunol 2000, 165:2950-2954.
• [28]Yamakawa N, Uchida T, Matthay MA, Makita K: Proteolytic release of the receptor for advanced glycation end products from in vitro and in situ alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol 2011, 300:L516-L525.
• [29]Damas P, Ledoux D, Nys M, Vrindts Y, De Groote D, Franchimont P, Lamy M: Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg 1992, 215:356-362.
• [30]Yeh CL, Hsu CS, Yeh SL, Chen WJ: Dietary glutamine supplementation modulates Th1/Th2 cytokine and interleukin-6 expressions in septic mice. Cytokine 2005, 31:329-334.
• [31]Singleton KD, Wischmeyer PE: Glutamine’s protection against sepsis and lung injury is dependent on heat shock protein 70 expression. Am J Physiol Regul Integr Comp Physiol 2007, 292:R1839-R1845.
• [32]Fukunaga K, Kohli P, Bonnans C, Fredenburgh LE, Levy BD: Cyclooxygenase 2 plays a pivotal role in the resolution of acute lung injury. J Immunol 2005, 174:5033-5039.
• [33]Badwey JA, Karnovsky ML: Active oxygen species and the functions of phagocytic leukocytes. Annu Rev Biochem 1980, 49:695-726.
• [34]Carnesecchi S, Pache JC, Barazzone-Argiroffo C: NOX enzymes: potential target for the treatment of acute lung injury. Cell Mol Life Sci 2012, 69:2373-2385.
• [35]Farley KS, Wang L, Mehta S: Septic pulmonary microvascular endothelial cell injury: role of alveolar macrophage NADPH oxidase. Am J Physiol Lung Cell Mol Physiol 2009, 296:L480-L488.
• [36]Sato K, Kadiiska MB, Ghio AJ, Corbett J, Fann YC, Holland SM, Thurman RG, Mason RP: In vivo lipid-derived free radical formation by NADPH oxidase in acute lung injury induced by lipopolysaccharide: a model for ARDS. FASEB J 2002, 16:1713-1720.
• [37]Winterbourn CC, Kettle AJ: Reactions of superoxide with myeloperoxidase and its products. Jpn J Infect Dis 2004, 57:S31-S33.
• [38]Wu F, Liu Y, Lv X, Miao X, Sun Y, Yu W: Small interference RNA targeting TLR4 gene effectively attenuates pulmonary inflammation in a rat model. J Biomed Biotechnol 2012, 2012:406435.
• [39]Wischmeyer PE, Kahana M, Wolfson R, Ren H, Musch MM, Chang EB: Glutamine reduces cytokine release, organ damage, and mortality in a rat model of endotoxemia. Shock 2001, 16:398-402.
• [40]Yeh CL, Hsu CS, Yeh SL, Lin MT, Chen WJ: Dietary glutamine supplementation reduces cellular adhesion molecule expression and tissue myeloperoxidase activity in mice with gut-derived sepsis. Nutrition 2006, 22:408-413.
• [41]Imai Y, Kuba K, Neely GG, Yaghubian-Malhami R, Perkmann T, van Loo G, Ermolaeva M, Veldhuizen R, Leung YH, Wang H, Liu H, Sun Y, Pasparakis M, Kopf M, Mech C, Bavari S, Peiris JS, Slutsky AS, Akira S, Hultqvist M, Holmdahl R, Nicholls J, Jiang C, Binder CJ, Penninger JM: Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 2008, 133:235-249.